Cited by 27Hormonal and reproductive studiesHIV-related health complications and treatmentsHypothalamic control of reproductive hormones

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

The importance of SHBG and calculated free testosterone for the diagnosis of symptomatic hypogonadism in HIV-infected men: a single-centre real-life experience

Open access

Abstract

Purpose: The prevalence of low testosterone and symptoms of hypogonadism in HIV-infected men is still debated. We aimed to estimate the prevalence and type of hypogonadism in HIV-infected males complaining about sexual symptoms, and to evaluate the role of calculated free testosterone (cFT) vs total testosterone (TT) for diagnosis. Furthermore, we evaluated relationship between sex hormone-binding globulin (SHBG), gonadal status and clinical and virologic parameters. Methods: We retrospectively evaluated 169 HIV-infected men with sexual symptoms, with TT available. Among them, we selected 94 patients with TT, SHBG, cFT, and luteinizing hormone (LH) available, and classified hypogonadism into overt (low TT and/or low cFT) and compensated (high LH, normal TT and cFT). Comparison was performed by non-parametric Kruskal–Wallis test and Spearman’s correlation was calculated to verify the possible associations. Results: Overt and compensated hypogonadism were found in 20.2% and 13.8% of patients, respectively. With reliance on TT alone, only 10.6% of patients would have met diagnosis. SHBG values were elevated in one third of patients, and higher in men with compensated hypogonadism. Significant positive correlation was found between SHBG and HIV infection duration, TT and LH. Conclusion: Only a complete hormonal profile can properly diagnose and classify hypogonadism in HIV-infected men complaining about sexual symptoms. TT alone reliance may lead to half of diagnoses missing, while lack of gonadotropin prevents the identification of compensated hypogonadism. This largely comes from high SHBG, which seems to play a central role in the pathogenesis of hypogonadism in this population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s15010-020-01558-6

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In HIV-positive men, underdiagnosis of male hypogonadism would have occurred in one third to half of the study subjects if only total T was measured as opposed to combining it with free T.

    “Moreover, in HIV-positive men, underdiagnosis of male hypogonadism would have occurred in one third to half of the study subjects if only total T was measured as opposed to combining it with free T [183, 184].”

    From Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology (2022) · cites this paper as [184]

    The Results report that measuring total testosterone alone would have missed 12 of 22 diagnoses in the 118-person group. The Discussion describes this as nearly half of diagnoses, and reports a one-third figure from another study. Neither figure refers to one third to half of all study subjects; the 12 missed cases were about 10% of that group. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 24

  1. Dean JD, McMahon CG, Guay AT, Morgentaler A, Althof SE, Becher EF, et al. The international society for sexual medicine’s process of care for the assessment and management of testosterone deficiency in adult men. J Sex Med. 2015;12:1660–86. https://doi.org/10.1111/jsm.12952. · DOI
  2. Kwong JCC, Krakowsky Y, Grober E. Testosterone deficiency: a review and comparison of current guidelines. J Sex Med. 2019;16:812–20. https://doi.org/10.1016/j.jsxm.2019.03.262. · DOI
  3. Maffezzoni F, Porcelli T, Delbarba A, Pezzaioli LC, Properzi M, Cappelli C, et al. Hypogonadism and osteoporosis in HIV-infected males: a narrative and critical review and future perspectives. Lancet HIV 2020; 7:e782–90. · DOI
  4. Gomes AR, Souteiro P, Silva CG, Sousa-Pinto B, Almeida F, Sarmento A, et al. Prevalence of testosterone deficiency in HIV-infected men under antiretroviral therapy. BMC Infect Dis. 2016;16:628. https://doi.org/10.1186/s12879-016-1892-5. · DOI
  5. Monroe AK, Dobs AS, Palella FJ, Kingsley LA, Witt MD, Brown TT. Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism. AIDS Res Ther. 2014;11:6. https://doi.org/10.1186/1742-6405-11-6. · DOI · Paper page
  6. Moreno-Pérez O, Escoín C, Serna-Candel C, Portilla J, Boix V, Alfayate R, et al. The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males. J Sex Med. 2010;7:2873–83. https://doi.org/10.1111/j.1743-6109.2010.01886.x. · DOI
  7. Shaiykova A, Pasquet A, Goujard C, Lion G, Durand E, Bayan T, et al. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors. AIDS. 2018;32:2689–96. https://doi.org/10.1097/QAD.0000000000002001. · DOI
  8. Lachâtre M, Pasquet A, Ajana F, Soudan B, Lion G, Bocket L, et al. HIV and hypogonadism: a new challenge for young-aged and middle-aged men on effective antiretroviral therapy. AIDS. 2017;31:451–3. https://doi.org/10.1097/QAD.0000000000001348. · DOI
  9. Pepe J, Isidori AM, Falciano M, Iaiani G, Salotti A, Diacinti D, et al. The combination of FRAX and ageing male symptoms scale better identifies treated HIV males at risk for major fracture. Clin Endocrinol (Oxf). 2012;77:672–8. https://doi.org/10.1111/j.1365-2265.2012.04452.x. · DOI
  10. Sunchatawirul K, Tantiwongse K, Chathaisong P, Thongyen S, Chumpathat N, Manosuthi W. Hypogonadism among HIV-infected men in Thailand. Int J STD AIDS. 2012;23:876–81. https://doi.org/10.1258/ijsa.2012.011464. · DOI
  11. Rochira V, Zirilli L, Orlando G, Santi D, Brigante G, Diazzi C, et al. Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PLoS ONE. 2011;6:e28512. https://doi.org/10.1371/journal.pone.0028512. · DOI
  12. Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014;58:1–10. https://doi.org/10.1093/cid/cit757. · DOI
  13. Tajar A, Forti G, O’Neill TW, Lee DM, Silman AJ, Finn JD, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95:1810–8. https://doi.org/10.1210/jc.2009-1796. · DOI · Paper page
  14. Ferlin A, Vinanzi C, Selice R, Garolla A, Frigo AC, Foresta C. Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter. Fertil Steril. 2011;96:1344-9.e2. https://doi.org/10.1016/j.fertnstert.2011.09.034. · DOI
  15. Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, Grinspoon S. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis. 2000;31:1240–4. https://doi.org/10.1086/317457. · DOI
  16. Rochira V, Diazzi C, Santi D, Brigante G, Ansaloni A, Decaroli MC, et al. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study. Andrology. 2015;3:298–308. https://doi.org/10.1111/andr.310. · DOI
  17. Bajaj S, Pathak Y, Varma S, Verma S. Metabolic status and hypogonadism in human immunodeficiency virus-infected males. Indian J Endocrinol Metab. 2017;21:684–7. https://doi.org/10.4103/ijem.IJEM_127_17. · DOI
  18. Crum-Cianflone NF, Bavaro M, Hale B, Amling C, Truett A, Brandt C, et al. Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS. 2007;21:9–19. https://doi.org/10.1089/apc.2006.0071. · DOI
  19. Sterling J, Bernie AM, Ramasamy R. Hypogonadism: Easy to define, hard to diagnose, and controversial to treat. Can Urol Assoc J. 2015;9:65–8. https://doi.org/10.5489/cuaj.2416. · DOI
  20. Corona G, Rastrelli G, Dicuio M, Concetti S, Minnetti M, Pivonello R, et al. Subclinical male hypogonadism. Minerva Endocrinol. 2020. https://doi.org/10.23736/S0391-1977.20.03208-3. · DOI
  21. Hyde Z, Norman PE, Flicker L, Hankey GJ, McCaul KA, Almeida OP, et al. Elevated LH predicts ischaemic heart disease events in older men: the Health in Men Study. Eur J Endocrinol. 2011;164:569–77. https://doi.org/10.1530/EJE-10-1063. · DOI
  22. Aggarwal J, Taneja RS, Gupta PK, Wali M, Chitkara A, Jamal A. Sex hormone profile in human immunodeficiency virus-infected men and it’s correlation with CD4 cell counts. Indian J Endocrinol Metab. 2018;22:328–34. https://doi.org/10.4103/ijem.IJEM_694_17. · DOI
  23. Corona G, Torres LO, Maggi M. Testosterone therapy: what we have learned from trials. J Sex Med. 2020;17:447–60. https://doi.org/10.1016/j.jsxm.2019.11.270. · DOI
  24. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363:123–35. https://doi.org/10.1056/NEJMoa0911101. · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Pezzaioli, L. C., Quiros-Roldan, E., Paghera, S., Porcelli, T., Maffezzoni, F., Delbarba, A., Degli Antoni, M., Cappelli, C., Castelli, F., & Ferlin, A.
Affiliations
  • University of Brescia (IT)
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT)
Corresponding author
Ferlin, Alberto
Venue
Infection
Published
2020-12-08
Volume
49
Issue
2
Pages
295-303
ISSN
  • 0300-8126 (ISSN-L)
  • 1439-0973
OpenAlex
W3110729192
Cited by
27
References
3
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 6
FWCI
3.39
Type
journal article
Language
en
Open access
Locations
  • Infection (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
Università degli Studi di Brescia
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
hypogonadism, HIV infection, sex hormone-binding globulin, free testosterone, total testosterone, luteinizing hormone, sexual symptoms, androgen deficiency, HIV duration
MeSH terms
Humans, Hypogonadism, Male, Retrospective Studies, Sex Hormone-Binding Globulin, Testosterone, HIV Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review